Manuel Lopez Meseguer
Overview
Explore the profile of Manuel Lopez Meseguer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopez Meseguer M, Saez Gimenez B
Arch Bronconeumol
. 2024 Nov;
61(2):63-64.
PMID: 39500654
No abstract available.
2.
Cruz-Utrilla A, Perez-Olivares C, Luna-Lopez R, Lopez-Guarch C, Bedate P, Martinez Menaca A, et al.
Arch Bronconeumol
. 2024 Mar;
60(5):321-323.
PMID: 38461109
No abstract available.
3.
Cruz-Utrilla A, Gallego-Zazo N, Perez-Olivares C, Hernandez-Gonzalez I, Bedate P, Martinez Menaca A, et al.
Rev Esp Cardiol (Engl Ed)
. 2022 Nov;
76(6):460-467.
PMID: 36403940
Introduction And Objectives: Risk stratification in pulmonary arterial hypertension (PAH) is essential to provide more aggressive treatment for patients at higher risk. Nevertheless, recently introduced simplified prognostic tools neglect the...
4.
Di Micco P, Salazar V, Fernandez Capitan C, Dentali F, Gomez Cuervo C, Torres J, et al.
Life (Basel)
. 2022 Aug;
12(8).
PMID: 36013307
Background: The use of rivaroxaban in clinical practice often deviates from manufacturer prescribing information. No studies have demonstrated an association between this practice and improved outcomes. Methods: We used the...
5.
Guillen-Del-Castillo A, Lopez Meseguer M, Fonollosa-Pla V, Saez Gimenez B, Colunga-Arguelles D, Revilla-Lopez E, et al.
Sci Rep
. 2022 Jul;
12(1):12947.
PMID: 35902683
No abstract available.
6.
Rodriguez-Perez A, Bos L, Podzamczer I, Lopez Meseguer M, Mayos-Perez M, Leta R
CASE (Phila)
. 2022 Jul;
6(5):228-232.
PMID: 35832825
No abstract available.
7.
Piccari L, Wort S, Meloni F, Rizzo M, Price L, Martino L, et al.
Respiration
. 2022 Apr;
101(8):717-727.
PMID: 35462365
Background: The impact of the new "borderline" hemodynamic class for pulmonary hypertension (PH) (mean pulmonary artery pressure [mPAP], 21-24 mm Hg and pulmonary vascular resistance, [PVR], ≥3 wood units, [WU])...
8.
Guillen-Del-Castillo A, Lopez Meseguer M, Fonollosa-Pla V, Saez Gimenez B, Colunga-Arguelles D, Revilla-Lopez E, et al.
Sci Rep
. 2022 Mar;
12(1):5289.
PMID: 35347225
To assess severity markers and outcomes of patients with systemic sclerosis (SSc) with or without pulmonary arterial hypertension (PAH-SSc/non-PAH-SSc), and the impact of interstitial lung disease (ILD) on PAH-SSc. Non-PAH-SSc...
9.
Saez-Gimenez B, Clofent D, Lopez Meseguer M, Bravo Masgoret C, Monforte V, Berastegui C, et al.
Respir Med
. 2021 Sep;
188:106584.
PMID: 34560353
Background: Venous thromboembolism (VTE) is a major complication after lung transplantation (LT). However, its pathophysiology remains unknown, and coagulation profiles have yet to be described. Objective: The aim of this...
10.
Martinez Menaca A, Blanco Vich I, Lopez Meseguer M, Lopez Reyes R, Bedate Diaz P, Elias Hernandez T, et al.
Adv Ther
. 2021 Mar;
38(4):1860-1875.
PMID: 33675523
Introduction: Self-perceived health-related quality of life (HRQoL) of patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) and their experience with the care received are important for...